Post-approval studies (Phase 4)Study completedNCT01608269
What this trial is testing
Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy
Who this might be right for
HiV1- Positive
Therapeutic Concepts 30